Study to Evaluate the Efficacy and Safety of PB-201 in Type 2 Diabetic Mellitus Patients With Poor Glycemic Control Via Metformin Hydrochloride Monotherapy
Clinical trial NCT05326490 · UNKNOWN
Trial details
- NCT number
- NCT05326490
- Sponsor
- PegBio Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-30
- Primary completion
- 2024-09-24
- Enrollment
- 546
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.